Navigation Links
Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
Date:7/30/2008

FORT WORTH, Texas, July 30 /PRNewswire/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today an evidence based study with a NE podiatric clinic evaluating the clinical performance of their advanced wound care collagen product, CellerateRx(R), on diabetic venous ulcers. "According to data released by the Centers for Disease Control and Prevention, diabetes now affects nearly 24 million people in the United States alone," states Cathy Bradshaw, President of Wound Care Innovations. Venous stasis ulcers of the lower extremity is a common problem among diabetic patients and presents significant quality of life issues for them as well as tremendous costs to the healthcare system. It has been estimated that venous ulcers cause the loss of approximately 2 million working days and incur treatment costs of approximately $3 billion per year in the United States.(1) "We have had very positive feedback from clinicians using CellerateRx(R) on these types of wounds. We look forward to providing this data to the medical community," Bradshaw said.

(1) New England Journal of Medicine, Bergan et al

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (WNDM), Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information visit http://www.Celleraterx.com .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this
'/>"/>

SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Bodys Own Naturally Occurring Stem Cells
2. Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
3. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
4. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
5. Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
6. Wound Management Technologies, Inc. Announces Evidence Based Study
7. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
8. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
9. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
10. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
11. U.S. Preventive Medicine Acquires Specialty Disease Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market ... Scanner Industry, 2009-2019 is a professional and in-depth ... Crystallography Scanner industry . The report firstly reviews ... its classification, application and manufacturing technology. The report ... X-Ray Crystallography Scanner listing their product specification, capacity, ...
(Date:8/29/2014)... 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), ... support services for the lawfully organized cannabis industry, ... approved the Company,s name and symbol change request. ... be known as Chuma Holdings, Inc. ... merger with the Company,s wholly-owned subsidiary, Chuma Holdings, ...
(Date:8/29/2014)... HILL, N.C. , Aug. 29, 2014 ... Leaders (KOLs) can be the difference between a product,s ... to effectively map and stratify KOL targets – and ... build the type of strong relationships upon which successful ... research, savvy pharma companies have identified internal inconsistencies in ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., a ... industry, announced that it is the first CRO on ... the company,s preclinical and early phase clinical GMP supply ... move our customers, drug candidates into the clinic more ...
... The next major personalized medicine advances will create therapies that ... health care industry to gain access, the inventor of the ... Medical Center,s Personalized Health Care National Conference ... for Systems Biology, said personalized medicine,s first "killer apps" - ...
Cached Medicine Technology:Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2Personalized Medicine 'Killer Apps' Will Transform Care Model 2
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to ... Reduce Painkiller Overdoses (8/25), a new study found ... reduce pain have seen a significant decrease in the ... information over a ten year period, and comparing various ... able to find that there was about a 25% ...
(Date:8/29/2014)... As reported by WKMS.com in the article ... Ohio municipal court drug has come up with a new ... serves as the presiding judge in a Southeastern Ohio municipal ... addicts a medicated treatment option that can literally prevent them ... as Vivitrol, which blocks receptors in the brain that would ...
(Date:8/29/2014)... As reported by CNN.com in the article Prescription Drug ... that you need help for a prescription drug abuse problem ... fact that if you simply try to find general help ... of the information that is available online. Although the information ... still possible to get help. The statistics from SAMSHA remind ...
(Date:8/29/2014)... reported by GantDaily.com in the article NIDA Switches to ... the National Institute on Drug Abuse is taking new measures ... to social media. As NIDA currently relies on community surveillance ... the University of Maryland to create a monitoring system known ... funded by the National Institute of Health. The project is ...
(Date:8/29/2014)... USA (PRWEB) August 29, 2014 According to ... Peers, But Not Peer Pressure, Key to Prescription Drug Misuse ... the primary focus for 18-29 year olds when it comes ... that the for this age group the real problem which ... drugs, drug associations and recreational use of them to have ...
Breaking Medicine News(10 mins):Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3
... NY, October 29, 2010Women experience and interact with their natural ... in which those differences affect a woman,s sense of self, ... are explored in a thought-provoking special issue of ... Liebert, Inc. ( www.liebertpub.com ). The entire issue is available ...
... , FRIDAY, Oct. 29 (HealthDay News) -- Lack ... children with the drug-resistant staph bacteria called MRSA (methicillin-resistant ... staff need to do a better job of educating ... said the researchers at the Johns Hopkins Children Center ...
... YORK (Oct. 28, 2010) -- Scientists at Weill Cornell Medical ... and Hendra viruses, two lethal and emerging viruses for which ... could also lead to new therapies for measles, mumps and ... the prestigious journal Public Library of Science (PLoS) Pathogens ...
... - A study in the New England Journal of ... kind of lung cancer are responding positively to a treatment ... study shows 57 percent of patients with ALK-positive advanced non-small ... called crizotinib, an investigational anaplastic lymphoma kinase (ALK) inhibitor. In ...
... of Wisconsin are conducting the KAST clinical trial ... effectiveness of a new vertebral augmentation treatment (Kiva) ... osteoporosis. Sean Tutton, M.D, associate ... College, is principal interventional radiology investigator for this ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, Oct. ... the brain,s ability to detect and correct errors, such as ... , Researchers had three groups of 24 skilled typists use ... inserted typographical errors or removed them from the typed text ...
Cached Medicine News:Health News:Women's unique connection to nature is explored in special issue of Ecopsychology 2Health News:Many Parents in the Dark About Drug-Resistant Infections: Study 2Health News:Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers 2Health News:People with specific kind of lung cancer respond to new targeted treatment 2Health News:People with specific kind of lung cancer respond to new targeted treatment 3Health News:National research study to assess new treatment for painful vertebral fractures 2Health News:Brain's Error-Detection System Demystified 2
Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis te...
Inquire...
... II (Low Melt), A low temperature ... melting temperature , Optimal for in-gel restriction ... forms a very manageable clear gel that ... Melts at approximately 65°C and remains fluid ...
... Agarose, Molecular Biology Grade, is ... of nucleic acids. It can ... fragments from 0.2 to 40 ... Agarose is tested and certified ...
Medicine Products: